Drug Profile
Ibuprofen/paracetamol - AFT Pharmaceuticals/Hyloris Pharmaceuticals
Alternative Names: Acetaminophen/ibuprofen - AFT Pharmaceuticals; Acetaminophen/ibuprofen intravenous - AFT Pharmaceuticals; Acetaminophen/ibuprofen IV - AFT Pharmaceuticals; COMBOGESIC; Combogesic IV; Dolerin; Maxigesic; Maxigesic IV; Maxigesic IV.; Paracetamol/ibuprofen intravenous - AFT PharmaceuticalsLatest Information Update: 20 Mar 2024
Price :
$50
*
At a glance
- Originator AFT Pharmaceuticals; Hyloris Pharmaceuticals
- Developer AFT Pharmaceuticals; Ever Pharma; Hyloris Pharmaceuticals; Karo Pharma AB
- Class Acetanilides; Amines; Aminophenols; Anti-inflammatories; Antipyretics; Non-opioid analgesics; Phenylpropionates; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; Cyclooxygenase inhibitors; Cytochrome P 450 enzyme system inhibitors; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Fever; Pain; Postoperative pain